
OpenAI Declares Code Red, Apple’s AI Chief Steps Down
The Rundown
00:00
Janix Therapeutics' Trial Reaction
Zaid explains Janix's stock plunge despite positive prostate cancer trial results and volatility in pharma stocks.
Play episode from 07:23
Transcript


